Old Web
English
Sign In
Acemap
>
authorDetail
>
Joanna Yi
Joanna Yi
Boston Children's Hospital
SMARCB1
Cancer
Synovial sarcoma
Immunology
Oncology
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors.
2020
Journal of Clinical Oncology
Susan N. Chi
Franck Bourdeaut
Theodore W. Laetsch
Maryam Fouladi
Margaret E. Macy
Guy Makin
Neerav Shukla
Cynthia Wetmore
Ashley Margol
Michela Casanova
Lindsay Kilburn
Joanna Yi
Darren Hargrave
Geoffrey McCowage
Navin Pinto
David H. Ebb
Giles W. Robinson
Laura Sierra
Melinda S. Merchant
Karsten Nysom
Show All
Source
Cite
Save
Citations (7)
Abstract A175: Phase 1 study of the EZH2 inhibitor, tazemetostat, in children with relapsed or refractory INI1-negative tumors including rhabdoid tumors, epithelioid sarcoma, chordoma, and synovial sarcoma
2018
Molecular Cancer Therapeutics
Susan N. Chi
Maryam Fouladi
Neerav Shukla
Franck Bourdeaut
Ashley Margol
Guy Makin
Geoff McCowage
Cynthia Wetmore
Margaret E. Macy
Ted Laetsch
Darren Hargrave
Navin Pinto
Joanna Yi
Dave Ebb
Giles W. Robinson
Maria Roche
Benjamin B. Suttle
Alicia Clawson
Peter Ho
Jill Rodstrom
Scott R. Daigle
Karsten Nysom
Show All
Source
Cite
Save
Citations (5)
1